Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel prophylactic and therapeutic vaccine against tuberculosis.
Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Inoue Y, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M. Okada M, et al. Among authors: kanamaru n. Vaccine. 2009 May 26;27(25-26):3267-70. doi: 10.1016/j.vaccine.2009.01.064. Epub 2009 Feb 5. Vaccine. 2009. PMID: 19200841
A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model.
Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, Nagasawa T, Kaneda Y, Yoshida S, Matsumoto M, Paul S, Tan EV, Cruz ECD, N McMurray D, Sakatani M. Okada M, et al. Among authors: kanamaru n. Procedia Vaccinol. 2010;2(1):34-39. doi: 10.1016/j.provac.2010.03.007. Epub 2010 Apr 14. Procedia Vaccinol. 2010. PMID: 32288910 Free PMC article.
Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
Kita Y, Tanaka T, Yoshida S, Ohara N, Kaneda Y, Kuwayama S, Muraki Y, Kanamaru N, Hashimoto S, Takai H, Okada C, Fukunaga Y, Sakaguchi Y, Furukawa I, Yamada K, Inoue Y, Takemoto Y, Naito M, Yamada T, Matsumoto M, McMurray DN, Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Skeiky Y, Reed S, Sakatani M, Okada M. Kita Y, et al. Among authors: kanamaru n. Vaccine. 2005 Mar 18;23(17-18):2132-5. doi: 10.1016/j.vaccine.2005.01.057. Vaccine. 2005. PMID: 15755583
The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice.
Okada M, Takemoto Y, Okuno Y, Hashimoto S, Yoshida S, Fukunaga Y, Tanaka T, Kita Y, Kuwayama S, Muraki Y, Kanamaru N, Takai H, Okada C, Sakaguchi Y, Furukawa I, Yamada K, Matsumoto M, Kase T, Demello DE, Peiris JS, Chen PJ, Yamamoto N, Yoshinaka Y, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M. Okada M, et al. Among authors: kanamaru n. Vaccine. 2005 Mar 18;23(17-18):2269-72. doi: 10.1016/j.vaccine.2005.01.036. Vaccine. 2005. PMID: 15755609 Free PMC article.
DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Yoshida S, Tanaka T, Kita Y, Kuwayama S, Kanamaru N, Muraki Y, Hashimoto S, Inoue Y, Sakatani M, Kobayashi E, Kaneda Y, Okada M. Yoshida S, et al. Among authors: kanamaru n. Vaccine. 2006 Feb 20;24(8):1191-204. doi: 10.1016/j.vaccine.2005.08.103. Epub 2005 Sep 19. Vaccine. 2006. PMID: 16216394
Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.
Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Fukamizu R, Tsunai Y, Inoue R, Nakatani H, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Gelber R, Sakatani M. Okada M, et al. Among authors: kanamaru n. Vaccine. 2007 Apr 20;25(16):2990-3. doi: 10.1016/j.vaccine.2007.01.014. Epub 2007 Jan 22. Vaccine. 2007. PMID: 17280753
Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models.
Okada M, Okuno Y, Hashimoto S, Kita Y, Kanamaru N, Nishida Y, Tsunai Y, Inoue R, Nakatani H, Fukamizu R, Namie Y, Yamada J, Takao K, Asai R, Asaki R, Kase T, Takemoto Y, Yoshida S, Peiris JS, Chen PJ, Yamamoto N, Nomura T, Ishida I, Morikawa S, Tashiro M, Sakatani M. Okada M, et al. Among authors: kanamaru n. Vaccine. 2007 Apr 20;25(16):3038-40. doi: 10.1016/j.vaccine.2007.01.032. Epub 2007 Jan 23. Vaccine. 2007. PMID: 17289225 Free PMC article.
Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models.
Kita Y, Okada M, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Takamori Y, McMurray DN, De la Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M. Kita Y, et al. Among authors: kanamaru n. Hum Vaccin. 2011 Jan-Feb;7 Suppl:108-14. doi: 10.4161/hv.7.0.14571. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21263229
Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosis.
Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Nishimatsu S, Sekine Y, Inoue Y, McMurray DN, Sakatani M. Okada M, et al. Among authors: kanamaru n. Clin Dev Immunol. 2011;2011:549281. doi: 10.1155/2011/549281. Epub 2011 Mar 7. Clin Dev Immunol. 2011. PMID: 21437226 Free PMC article.
20 results